🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare
$93.9 +$0.35 (0.38%)
Market Cap: $7.38 B
Gurus Holding
5
Popularity Rank
#1997
% of Shares Held
1.88%
Net Activity (Q3 2026)
-$2.07 M

Guru Ownership Trend

Guru Analysis for Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $138.77 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.07 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 143.1%. Conversely, Ken Fisher reduced exposure by 18.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$11.81 M
Total Buy Value
New Buys 0
Additions 2
-$13.88 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Kiniksa Pharmaceuticals International, plc (KNSA)

Major holders include Steven Cohen ($40.92 M), Cliff Asness ($32.53 M), Ken Fisher ($24.16 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.48 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.07 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited KNSA. The total reported sell value was $13.88 M.

Yes, 0 managers opened new positions in KNSA, and 2 increased their existing holdings. The total reported buy value was $11.81 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.05% Reduce -16.8% 548,496 $40.92 M Q3 2026
0.01% Add 16.2% 435,935 $32.53 M Q3 2026
0.01% Reduce -18.7% 323,808 $24.16 M Q3 2026
0.02% Add 143.1% 165,477 $12.35 M Q3 2026
0.00% Reduce -12.1% 4,219 $314,780 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form